| |
|
|
|
Caladrius Bio  
|
|
2.24 0.09 (0.04%) |
08-14 16:00 |
|
Open: |
2.33 |
Pre close: |
2.15 |
Target:
|
3.22 
|
|
High: |
2.44 |
Low: |
2.2 |
Resistance:
|
2.76
3.21
|
|
Volume: |
932,844 |
Market Cap: |
35M |
Support:
|
2.02
1.68
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.24
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
2.37 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
2.06 |
Stochastic Oscillator |
%K(14,3):
|
22.04 |
|
MA(250): |
2.33 |
%D(3): |
24.78 |
|
Average Volume(K) |
3-Month: |
82193
|
52-Week |
High:
|
3.64 |
|
10-Days: |
53984 |
Low: |
1.05 |
|
RSI |
RSI(14):
|
48.58 |
Change(%): |
-5.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.812 |
Return on Equity (ttm) |
-73.8 |
Shares Out. (M) |
15.55 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-38.5 |
Shares Float (M) |
9.43 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.89 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.84 |
|
Forward EPS |
-1.880 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
170 |
|
Book Value (p.s.) |
1.620 |
EBITDA (p.s.) |
-1.253 |
P/E |
-1.24 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.38 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.64 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.55 |
P/CF |
-1.97 |
|
|
|
|
|
|
